IPPF Research Grant Program Now Calling for Applicants
January 17, 2017
Organization: International Pemphigus & Pemphigoid Foundation
The International Pemphigus and Pemphigoid Foundation (IPPF) is pleased to announce the availability of a seed grant program to encourage and support Patient Oriented Research on pemphigus and pemphigoid. The intent of the grant is to support well-defined research projects that have a specified benefit for improving the treatment, health, disease management or diagnosis of persons with pemphigus and pemphigoid. Consideration will also be given to studies that contribute to the body of medical knowledge in pemphigus and pemphigoid.
The program is open to applicants currently based in the U.S. and will consist of one-year grants. Award Value: $25,000 – $50,000.
Schedule for Applications:
Letter of Intent deadline for FY 2017 is February 28, 2017.
The application deadline for FY 2017 is March 31, 2017.
2017 award announcements will be made on June 30, 2017.
Funds available August 1, 2017.
Each research proposal is reviewed by IPPF’s Research Committee, which recommends funding for the highest scored proposals. The grant review process is based on the peer review system utilized by the National Institutes of Health (NIH). Scoring of grants is done individually by each member of the Research Committee and scores are added together to determine the final ranking of each proposal. Any reviewer with a conflict of interest is excused from voting on a specific proposal. The grant selection process is unbiased and independent; awards are based solely on scientific merit.
1. Download and complete the IPPF Research Grant Guidelines and Application Form found at: www.pemphigus.org
2. Attach the following: CVs and or bio-sketches, Letters of support/recommendation, and Letters from collaborators agreeing to participate
3. Submit the completed application with attachments to: [email protected]
The application, along with the attachments must be assembled and submitted electronically as a single PDF to [email protected]
Sign up for updates straight to your inbox.